SUPPLIER PROFILE

Chengdu Shengnuo Biopharm

Chengdu Shengnuo Biopharm is a company operating in the pharmaceutical industry.

Chengdu Shengnuo is one of the leading peptide manufacturers in China. There are 5 US-DMF of Peptide APIs: Liraglutide, Bivalirudin, Eptifibatide, Icatibant and Octreotide. The below US-DMFs will be submitted soon: Linaclotide, Degarelix, Teriparatide,Ziconotide,Exenatide and Ganirelix soon. Shengnuo also have a few Chinese GMP APIs: Atosiban,Carbetocin, Octreotide, Enfuvirtide,Thymalfasin, Somatostatin, Thymopentin and Levosimendan.

Company type

Products and services

Biopharmaceuticals, APIs (Active Pharmaceutical Ingredients)

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address


Chengdu Shengnuo Biopharm, Section 1, Gongye Avenue, Dayi County, Chengdu, Sichuan, China, 611330

Do you work for Chengdu Shengnuo Biopharm? Claim your profile here
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.